Literature DB >> 4700486

Metabolism of proinsulin, insulin, and C-peptide in the rat.

A I Katz, A H Rubenstein.   

Abstract

The renal extraction and excretion of bovine proinsulin, insulin, and C-peptide and the contribution of the kidney to their total metabolic clearance rate (MCR) were studied in the rat. Metabolic clearance rates were measured by the constant infusion technique and plasma and urine concentrations of each polypeptide were determined by radioimmunoassay. The MCR of insulin (16.4+/-0.4 ml/min) was significantly greater than that of either proinsulin (6.7+/-0.3 ml/min) or C-peptide (4.6+/-0.2 ml/min). Metabolic clearance rates were independent of plasma levels over a range of steady-state plasma concentrations varying from 1 to 15 ng/ml.In contrast to the differences in their metabolic clearance rates, the renal disposition of the three polypeptides was similar, being characterized by high extraction and very low urinary clearance. The renal arteriovenous difference of proinsulin, insulin, and C-peptide averaged 36, 40, and 44%, respectively, and was linearly related to their arterial concentration between 2 and 25 ng/ml. When glomerular filtration was markedly reduced or stopped by ureteral obstruction, the renal extraction of proinsulin, insulin, and C-peptide was invariably greater than the simultaneously measured extraction of inulin, indicating that these polypeptides are removed from the renal circulation by both glomerular filtration and direct uptake from peritubular capillary blood. The fractional urinary clearance of each polypeptide never exceeded 0.6%, indicating that more than 99% of the amount filtered was sequestered in the kidney. The renal removal of proinsulin and C-peptide from the circulation accounts for 55 and 69% of their metabolic clerance rates, while the renal contribution to the peripheral metabolism of insulin was smaller, averaging 33%. This difference is due to the fact that insulin, but not the other two polypeptides, is metabolized to a significant extent by the liver. These results define the renal handling of proinsulin, insulin, and C-peptide in the rat and indicate that in this species the kidney represents a major site for insulin metabolism and is the main organ responsible for the degradation of proinsulin and C-peptide.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4700486      PMCID: PMC302366          DOI: 10.1172/JCI107277

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

Review 1.  REVIEW: THE USE OF ISOTOPIC STEROIDS FOR THE MEASUREMENT OF PRODUCTION RATES IN VIVO.

Authors:  J F TAIT
Journal:  J Clin Endocrinol Metab       Date:  1963-12       Impact factor: 5.958

2.  Catabolsm of human beta-2-microglobulin by the rat kidney.

Authors:  G M Bernier; M E Conrad
Journal:  Am J Physiol       Date:  1969-11

3.  Renal inactivation of gastrin.

Authors:  B G Clendinnen; W D Davidson; B M Jackson; J C Thompson; A G Riddell
Journal:  Br J Surg       Date:  1970-11       Impact factor: 6.939

4.  Purification and characterization of a protease with specificity for insulin from rat muscle.

Authors:  J S Brush
Journal:  Diabetes       Date:  1971-03       Impact factor: 9.461

5.  Role of the kidney in the disposal of radioiodinated and nonradioiodinated insulin in dogs.

Authors:  D S Zaharko; L V Beck; R Blankenbaker
Journal:  Diabetes       Date:  1966-09       Impact factor: 9.461

6.  Human serum proinsulin.

Authors:  F Melani; A H Rubenstein; D F Steiner
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

7.  Angiotensin II in arterial and renal venous plasma and renal lymph in the dog.

Authors:  M D Bailie; F C Rector; D W Seldin
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

8.  Derivation of a three compartment model describing disappearance of plasma insulin-131-I in man.

Authors:  A Silvers; R S Swenson; J W Farquhar; G M Reaven
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

9.  Insulin delivery rate into plasma in normal and diabetic subjects.

Authors:  M P Stern; J W Farquhar; A Silvers; G M Reaven
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

10.  Glomerular permeability. Ultrastructural cytochemical studies using peroxidases as protein tracers.

Authors:  R C Graham; M J Karnovsky
Journal:  J Exp Med       Date:  1966-12-01       Impact factor: 14.307

View more
  62 in total

1.  The excretion of proinsulin and insulin in urine.

Authors:  L Constan; M Mako; D Juhn; A H Rubenstein
Journal:  Diabetologia       Date:  1975-04       Impact factor: 10.122

2.  Human C-peptide in normal and diabetic subjects.

Authors:  L G Heding; S M Rasmussen
Journal:  Diabetologia       Date:  1975-06       Impact factor: 10.122

3.  The renal handling of parathyroid hormone. Role of peritubular uptake and glomerular filtration.

Authors:  K J Martin; K A Hruska; J Lewis; C Anderson; E Slatopolsky
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

4.  Extrapancreatic insulin effect of glibenclamide.

Authors:  H Mulder; W Schopman; A J van der Lely
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

Authors:  D L Horwitz; J I Starr; M E Mako; W G Blackard; A H Rubenstein
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

6.  Insulin binding and degradation by luminal and basolateral tubular membranes from rabbit kidney.

Authors:  Z Talor; D S Emmanouel; A I Katz
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

7.  Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.

Authors:  L Gerö; L Korányi; F Szalay; B Büki; G Tamás
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar

Review 8.  The renal metabolism of insulin.

Authors:  R Rabkin; M P Ryan; W C Duckworth
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

9.  Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease.

Authors:  Laetitia Koppe; Elsa Nyam; Kevin Vivot; Jocelyn E Manning Fox; Xiao-Qing Dai; Bich N Nguyen; Dominique Trudel; Camille Attané; Valentine S Moullé; Patrick E MacDonald; Julien Ghislain; Vincent Poitout
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

10.  Human C-peptide. Part II: Clinical studies.

Authors:  W Beischer; E Heinze; L Keller; S Raptis; W Kerner; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1976-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.